Axillary node status is the most important prognostic information regarding
treatment and prognosis for breast cancer patients. Localisation and numbe
r of involved lymphnodes add further information and are of prognostic rele
vance as well. The problem of the involvement of different axilla levels as
well as skip metastases are discussed. Sentinel lymphnode dissection is st
ill considered investigational as well as axilla downstaging by preoperativ
e chemotherapy. New prognostic markers are helpful in individual situations
but are not yet considered as standard procedures. Conclusions of practica
l relevance are summarised.